Direct Medical Costs of Four Vaccine-Preventable Infectious Diseases in Older Adults in Spain.
Ángel Gil de MiguelJosé María Eiros BouzaLuis Ignacio Martínez AlcortaDaniel Callejo VelascoCarlos MiñarroLaura Amanda Vallejo-AparicioAndrea GarcíaMónica TafallaMaria Del Rosario CambroneroRubén RodríguezLaura Martin-GomezPublished in: PharmacoEconomics - open (2022)
The direct economic burden of herpes zoster, pneumococcal disease, influenza and pertussis in adults 45 years and older was high in Spain, and may be underestimated as it only considered medical assistance and not other applicable direct or indirect costs. Increasing vaccination rates in adults may potentially reduce the economic burden derived from these diseases, although future cost-effectiveness analysis including other disease-related costs, vaccination costs and vaccination effectiveness would be needed.